NEW YORK ACADEMY OF MEDICINE

NEW YORK, NEW YORK

2nd Annual Mount Sinai ADVANCED Heart Disease Symposium
October 20, 2017
New York, New York


Target Audience

The 2nd Annual Mount Sinai ADVANCED Heart Disease Symposium has been designed to meet the educational needs of General and Sub-Specialized Cardiologists, Cardiothoracic Surgeons, Nurses, Nurse Practitioners, Transplant Professionals, Fellows in Training, VAD Coordinators and Ancillary Staff committed to caring for complex cardiac patients.

Educational Goal

The goal of the 2nd Annual Mount Sinai ADVANCED Heart Disease Symposium is to provide health care professionals with important updates of advanced cardiac care and relevant clinical research in how to care for cardiac patients.

Learning Objectives

  • Describe the worldwide burden of cardiovascular disease
  • Recognize the clinical signs of congestion in heart failure patients
  • Determine the new clinical practice guidelines for the use of valsartan/sacubitril and ivabradine
  • Discuss the potential role of gene therapy for chronic systolic heart failure
  • Assess the role of viruses in the development of cardiomyopathy
  • Analyze the genetic basis for some forms of cardiomyopathy
  • Recognize the potential for cancer chemotherapeutic agents to cause cardiomyopathy
  • Assess the clinical signs of cardiac amyloidosis in susceptible individuals
  • Describe current strategies to assess for myocardial recovery following LVAD implantation
  • Describe the indications for catheter ablation of atrial fibrillation in heart failure patients
  • Explain the outcomes with catheter ablation for ventricular tachycardia in ischemic cardiomyopathy
  • Describe the role of percutaneous and surgical mitral valve repair for functional mitral regurgitation
  • Determine the indicated uses for temporary support devices in cardiac resuscitation and decision-making
  • Describe the major contributors to heart failure care disparities in minorities and women
  • Discuss the role of nursing and multidisciplinary teams for comprehensive heart failure care delivery
  • Describe the characteristics of patients with advanced heart failure (Stage D)
  • Recognize the triggers for referral for transplant and LVAD evaluation
  • Explain the major clinical outcomes following heart transplant and LVAD implantation

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of CMEsolutions and Gaffney Events. The CMEsolutions is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The CMEsolutions designates this live activity for a maximum of 8.00 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participation Requirements

  1. Complete sign in sheet
  2. Attend accredited sessions
  3. For credit log on to URL: http://online-med-edu.com/msahds2017
  4. Complete evaluation, credit request form, and download or print credit statement

Faculty and Disclosures

CMEsolutions requires everyone in a position to control the content of this activity to disclose any relevant financial conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by CMEsolutions for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty

Anelechi C. Anyanwu, MD
Professor, Cardiovascular Surgery, Surgical Director, Mechanical Circulatory Support and Heart Transplant Program, The Mount Sinai Hospital
New York, NY
Anelechi Anyanwu has no relevant financial relationships to disclose.

Maya Barghash, MD
Assistant Professor of Medicine, Cardiology, The Mount Sinai Hospital
New York, NY
Maya Barghash has no relevant financial relationships to disclose.

Johanna Contreras, MD, FACC
Assistant Professor, Cardiology, Heart Failure and Transplant, The Mount Sinai Hospital
New York, NY
Johanna Contreras has disclosed the following relevant financial relationships: Gilead Sciences, Inc., Novartis Pharmaceuticals- Consultant

Valentin Fuster, MD, PhD, MRCP, MACC, FSCAI
Professor of Medicine, Cardiology, Physician in Chief, Director, Zena and Michael A. Wiener Cardiovascular Institute, The Mount Sinai Hospital
New York, NY
Valentin Fuster has no relevant financial relationships to disclose.

Amy R. Kontorovich, MD
Assistant Professor (pending), Medicine, Cardiology, The Mount Sinai Hospital
New York, NY
Amy Kontorovich has no relevant financial relationships to disclose.

Jason Kovacic, MD, PhD, FACC, FSCAI
Associate Professor of Medicine, Cardiology, The Mount Sinai Hospital
New York, NY
Jason Kovacic has no relevant financial relationships to disclose.

Anu Lala, MD
Director, Heart Failure Research, The Mount Sinai Hospital
New York, NY
Anu Lala has no relevant financial relationships to disclose.

Barry A. Love, MD, FRCPc
Assistant Professor of Pediatrics and Medicine
Director, Congenital Cardiac Catheterization Laboratory, The Mount Sinai Hospital
New York, NY
Barry A. Love has no relevant financial relationships to disclose.

Donna M. Mancini, MD
Professor of Medicine, Heart Failure, Heart Transplant Population Health Science and Policy, The Mount Sinai Hospital
New York, NY
Donna Mancini has disclosed the following relevant financial relationships: Amgen – Speaker Bureau

Sumeet Mitter, MD
Assistant Professor of Medicine, Cardiology, The Mount Sinai Hospital
New York, NY
Sumeet Mitter has no relevant financial relationships to disclose.

Noah Moss, MD
Assistant Professor of Medicine, Cardiology
Medical Director Mechanical Circulatory Assist Program, The Mount Sinai Hospital
New York, NY
Noah Moss has no relevant financial relationships to disclose.

Jagat P. Narula, MD
Associate Dean for Global Affairs
Professor of Medicine, Cardiology, Radiology, The Mount Sinai Hospital
New York, NY
Jagat P. Narula has no relevant financial relationships to disclose.

Navneet Narula, MD
Professor of Clinical Pathology and Laboratory Medicine, Weill-Cornell Medicine, New York-Presbyterian
New York, NY
Navneet Narula has no relevant financial relationships to disclose.

Beth Oliver, DNP, RN
Senior Vice President of Cardiac Services, The Mount Sinai Hospital
New York, NY
Beth Oliver has no relevant financial relationships to disclose.

Milton Packer, MD
Distinguished Scholar in Cardiovascular Science, Baylor University Medical Center
Dallas, TX
Milton Packer has disclosed the following relevant financial relationships: Amgen, Astra Zeneca, Bayer, Boehringer Ingelheim, Cardiorentis , Celyad, Daiichi Sankyo, Relypsa, Sanofi, Takeda – Consultant

Amit A. Pawale, MD
Assistant Professor Cardiovascular Surgery, The Mount Sinai Hospital
New York, NY
Amit A. Pawale has no relevant financial relationships to disclose.

Sean Pinney, MD, FACC
Professor of Medicine, Cardiology; Director, Advanced Heart Failure and Transplantation Program, The Mount Sinai Hospital
Sean Pinney has disclosed the following relevant financial relationships: Abbott, CareDX - Honoraria

Vak Rakita, MD
Advanced Heart Failure Fellow, The Mount Sinai Hospital
New York, NY
Vak Rakita has no relevant financial relationships to disclose.

Vivek Y. Reddy, MD
Professor of Medicine, Cardiology, The Leona M. and Harry B. Helmsley Charitable Trust Professor of Medicine in Electrophysiology, The Mount Sinai Hospital
New York, NY
Vivek Reddy has disclosed the following relevant financial relationships: ACT-Consultant; Actus Medical-Ownership Interest

David L. Reich, MD
President & Chief Operating Officer Mount Sinai Hospital
Horace W. Goldsmith Professor of Anesthesiology, The Mount Sinai Hospital
New York, NY
David L. Reich has no relevant financial relationships to disclose.

Samin K. Sharma, MD, FACC, FSCAI
Zena & Michael A. Wiener Professor of Medicine, Director, Clinical & Interventional Cardiology,
President, Mount Sinai Heart Network, Dean, International Clinical Affiliations, The Mount Sinai Hospital
New York, NY
Samin Sharma has disclosed the following relevant financial relationships: Abbott Vascular, Boston Scientific, Cardiovascular Systems, Inc. - Honoraria

Gilbert H. Tang, MD
Assistant Professor, Cardiovascular Surgery, The Mount Sinai Hospital
New York, NY
Gilbert H. Tang has disclosed the following relevant financial relationships: Edwards Lifescience, Medtronic – Honoraria; Abbott Vascular – Consultant, Honoraria

Maria G. Trivieri, MD, PhD
Assistant Professor of Medicine, Cardiology Medical Director Pulmonary Hypertension, The Mount Sinai Hospital
New York, NY
Maria G. Trivieri has no relevant financial relationships to disclose.

Planner Disclosures

No member of CMEsolutions or Gaffney Events has any relevant financial relationships to disclose in regards to this activity.

Off-label Use

2nd Annual Mount Sinai ADVANCED Heart Disease Symposium may contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA.  Please consult the prescribing information for each product.

Commercial Support

Commercial Support for this educational activity is provided by
Abbott Laboratories
Alnylam pharmaceuticals, Inc.

Fees

There are registration fees associated with this symposium as outlined on the website.

Privacy Policy

CMEsolutions Privacy and Confidentiality Policy: www.online-med-edu.com/privacypolicy.pdf
CMEsolutions can be contacted at info@cmesolutions.org.


 complete evaluation/credit request